Epigenomics AG / Key word(s): Agreement/Capital Increase 28.10.2013 / 08:00 BioChain to acquire exclusive development and commercial Septin9 license for China BioChain to invest US$ 1.3 m in Epigenomics Initiation of large clinical study with the goal of gaining China Food and Drug Administration (CFDA) approval 5,000 Epi proColon(R) tests ordered for Q4 delivery Establishment […]
Year: 2013
28. October 2013
Epigenomics AG: Epigenomics and BioChain enter into broad strategic collaboration in China and investment into Epigenomics
Read more
27. October 2013
Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics and BioChain sign agreement for broad strategic collaboration in China
Epigenomics AG / Key word(s): Agreement 27.10.2013 19:50 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, October 27, 2013 – Epigenomics AG (ISIN: DE000A1K0516) announces that it has […]
27. October 2013
Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics issues new shares to BioChain – Investment follows agreement on broad strategic collaboration in China
Epigenomics AG / Key word(s): Capital Increase 27.10.2013 19:59 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, October 27, 2013 – Epigenomics AG (ISIN: DE000A1K0516) announces that BioChain […]
02. October 2013
Epigenomics AG: Epigenomics signs joint commercialization agreement for Epi proColon(R) in North America with Polymedco
Epigenomics AG / Key word(s): Agreement 02.10.2013 / 08:00 – Companies to join efforts in commercialization of Epi proColon(R) – Epigenomics to provide manufacturing, medical, regulatory and strategic marketing – Polymedco, the US leader in CRC screening products, to contribute logistics, sales, marketing and customer support Berlin, Germany, and U.S.A., October 2, 2013– Epigenomics AG […]
01. October 2013
Ad hoc Announcement Pursuant to § 15 WpHG (German Securities Trading Act): Epigenomics signs joint commercialization agreement for Epi proColon(R) in North America with Polymedco
Epigenomics AG / Key word(s): Agreement 02.10.2013 00:28 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Berlin, Germany, October 01, 2013 – Epigenomics AG (ISIN: DE000A1K0516) announces that it has […]
30. September 2013
Epigenomics AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG / Veröffentlichung der Gesamtzahl der Stimmrechte 30.09.2013 10:30 Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG, übermittelt durch die DGAP – ein Unternehmen der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. ————————————————————————— Hiermit teilt die Epigenomics AG mit, dass die Gesamtzahl der Stimmrechte am Ende des Monats […]